- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Serviscope gets cash infusion
Independent service organization Serviscope announced this month that it is acquiring $10.5 million in new equity. The infusion should be the last round of private financing before the Wallingford, CT, ISO seeks public funds,according to Emile
Independent service organization Serviscope announced this month that it is acquiring $10.5 million in new equity. The infusion should be the last round of private financing before the Wallingford, CT, ISO seeks public funds,according to Emile Geisenheimer, Serviscope chairman and generalpartner of Nazem & Co., Serviscope's lead investor.
Serviscope has grown dramatically since it was founded in 1990.The company's cash requirements have grown as well, and as a resultServiscope has recently received several rounds of private equityfinancing.
The latest round will ensure the company's long-term stabilityand growth and will support Serviscope as it pursues an aggressiveexpansion strategy, Geisenheimer said. The financing also putsServiscope on a track to go public in the near future.
While Serviscope sorts out its financial picture, the companyis still searching for a new chief executive to replace DonaldSouthard, who left the company earlier this year (SCAN 4/6/94).
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
